Decide at what price you'd be comfortable buying and we'll help you stay ready.
Paxman AB makes scalp-cooling systems used by cancer patients during chemotherapy. Its main product is a wearable cooling cap and the control equipment that keeps the scalp cold before, during, and after treatment. The goal is to reduce chemotherapy-related hair loss, which can matter a lot to patients’ quality of life.
The company sells these systems to hospitals, cancer clinics, and healthcare providers that treat oncology patients. It also earns money from consumables and service around the equipment, which helps create repeat business after the system is installed. In practice, Paxman sits between medical-device maker and treatment-support supplier: it provides the hardware, the treatment protocol, and the ongoing support needed to use scalp cooling in a clinic setting.
What makes the business distinct is that it focuses on a very specific part of cancer care rather than broad medical equipment. Its products are used alongside chemotherapy, so the customer is usually the treatment center, while the end user is the patient. That gives Paxman a niche role in oncology where demand is tied to cancer treatment adoption and the willingness of clinics to offer scalp cooling as part of patient care.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more